Cost-utility of transcatheter aortic valve implantation for inoperable patients with severe aortic stenosis treated by medical management: a UK cost-utility analysis based on patient-level data from the ADVANCE study

Abstract

TAVI is highly likely to be a cost-effective treatment for patients with severe aortic stenosis.